loading...| Preferred Name |
Lipoatrophy |
|
| Synonyms |
Atrophy of fat Loss of fat tissue in localized area Loss of fat tissue in localised area |
|
| Definitions |
This may occur as a result of subcutanous injections of insulin in the treatment of diabetes, from the use of human growth hormone or from subcutanous injections of Copaxone used for the treatment of multiple sclerosis. In the latter case, an injection may produce a small dent at the injection site. Lipoatrophy is also an adverse drug reaction that is associated with some antiretroviral drugs. Localized loss of fat tissue. |
|
| ID |
http://purl.obolibrary.org/obo/HP_0100578 |
|
| comment |
This may occur as a result of subcutanous injections of insulin in the treatment of diabetes, from the use of human growth hormone or from subcutanous injections of Copaxone used for the treatment of multiple sclerosis. In the latter case, an injection may produce a small dent at the injection site. Lipoatrophy is also an adverse drug reaction that is associated with some antiretroviral drugs. |
|
| creation_date |
2010-12-27T12:55:33Z |
|
| database_cross_reference |
SNOMEDCT_US:248315005 MEDDRA:10024604 UMLS:C1280433 |
|
| definition |
Localized loss of fat tissue. |
|
| has_exact_synonym |
Atrophy of fat Loss of fat tissue in localized area Loss of fat tissue in localised area |
|
| has_obo_namespace |
human_phenotype |
|
| id |
HP:0100578 |
|
| in_subset | ||
| label |
Lipoatrophy |
|
| notation |
HP:0100578 |
|
| prefLabel |
Lipoatrophy |
|
| terms_creator | ||
| treeView | ||
| subClassOf |